Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact?
10:05am, Tuesday, 29'th Apr 2025
DexCom Q1 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
07:34pm, Tuesday, 22'nd Apr 2025
SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc.
Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm
04:30pm, Tuesday, 22'nd Apr 2025
NEW YORK , April 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fi
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
06:30pm, Friday, 18'th Apr 2025
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DexCom, Inc. (NASDAQ: DXCM) on
Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs
12:51pm, Wednesday, 16'th Apr 2025
What Johnson & Johnson and Eli Lilly are saying about Trump's pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
08:50am, Wednesday, 16'th Apr 2025
SAN DIEGO, April 16, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc.
DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance
02:05pm, Friday, 11'th Apr 2025
DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and expanding diabetes care access.
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
01:28pm, Thursday, 10'th Apr 2025
The U.S. Food and Drug Administration approved DexCom, Inc.'s DXCM Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes.
DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance
11:34am, Thursday, 10'th Apr 2025
DexCom says its G7 15 Day system will land on the market in the second half of 2025.
2 Growth Stocks to Buy in the Tariff-Fueled Market Correction
10:15am, Thursday, 10'th Apr 2025
What should investors do during a market downturn? Some might resort to panic selling, but that's hardly a good strategy.
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System
08:30am, Thursday, 10'th Apr 2025
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for peopl
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
09:10am, Friday, 04'th Apr 2025
DXCM continues to raise investor optimism due to its strong product portfolio.
Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.
08:30am, Thursday, 03'rd Apr 2025
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1, 2025. Management will ho
Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems
08:00am, Tuesday, 01'st Apr 2025
BURNABY, British Columbia--(BUSINESS WIRE)--The Government of Saskatchewan expands public coverage for Dexcom Continuous Glucose Monitoring Systems.
